No, read my lips! Biocurex is currently in negotiations with other Pharmas and has garnered the interest of many in the industry. It is just a matter of time before they have other licensing deals in place.
My statements will completely nullify your contention because Biocurex will have at least one other licensee before Abbott has any recaf product on the market. My guess is within the next 6 months.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.